Debt-to-equity of G1 Therapeutics, Inc. from 30 Sep 2018 to 30 Jun 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
G1 Therapeutics, Inc. quarterly Debt-to-equity in % history and change rate from 30 Sep 2018 to 30 Jun 2024.
  • G1 Therapeutics, Inc. Debt-to-equity for the quarter ending 30 Jun 2024 was 248%, a 21% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

G1 Therapeutics, Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q2 2024 248% +42% +21% 30 Jun 2024
Q1 2024 208% -3% -1.4% 31 Mar 2024
Q4 2023 212% +42% +25% 31 Dec 2023
Q3 2023 194% +62% +47% 30 Sep 2023
Q2 2023 206% +121% +143% 30 Jun 2023
Q1 2023 211% +155% +275% 31 Mar 2023
Q4 2022 170% +131% +339% 31 Dec 2022
Q3 2022 132% +102% +342% 30 Sep 2022
Q2 2022 85% +56% +196% 30 Jun 2022
Q1 2022 56% +29% +106% 31 Mar 2022
Q4 2021 39% +15% +66% 31 Dec 2021
Q3 2021 30% +11% +59% 30 Sep 2021
Q2 2021 29% +15% +103% 30 Jun 2021
Q1 2021 27% +17% +178% 31 Mar 2021
Q4 2020 23% +16% +203% 31 Dec 2020
Q3 2020 19% +13% +225% 30 Sep 2020
Q2 2020 14% +9.9% +237% 30 Jun 2020
Q1 2020 9.8% +5.6% +132% 31 Mar 2020
Q4 2019 7.7% +2.9% +60% 31 Dec 2019
Q3 2019 5.8% -0.47% -7.5% 30 Sep 2019
Q2 2019 4.2% 30 Jun 2019
Q1 2019 4.2% 31 Mar 2019
Q4 2018 4.8% 31 Dec 2018
Q3 2018 6.3% 30 Sep 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.